AIM
VNDA icon

Assured Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Assured Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,869
Closed -$545K – 1367
2018
Q4 		$545K Sell
20,869
-5,064
-20% -$119K 0.02% 628
2018
Q3 		$595K Sell
25,933
-26,043
-50% -$532K 0.01% 711
2018
Q2 		$990K Sell
51,976
-30,654
-37% -$513K 0.02% 562
2018
Q1 		$1.39M Buy
+82,630
New +$1.38M 0.03% 445

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assured Investment Management's VNDA Position: Q1 2019 in Review

Assured Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2019, closing a stake of 20,869 shares — an estimated $545K sold.

Assured Investment Management first reported a position in VNDA in Q1 2018 and held it in 4 quarters. The position peaked at $1.39M in Q1 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q1 2019.

  • Assured Investment Management reported no remaining Vanda Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 20,869 Vanda Pharmaceuticals shares in Q1 2019, an estimated $545K.
  • Assured Investment Management first reported a position in Vanda Pharmaceuticals in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's Vanda Pharmaceuticals position peaked at $1.39M in Q1 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.